Table 1 Cumulative incidence for event R (loco-regional recurrence) of the SQNP01 trial
From: Analysis and design of randomised clinical trials involving competing risks endpoints
|
j
(1) |
t
j
(2) |
d
Rj
(3) |
n
j
(4) |
h
R
(t
j
) (5) |
EFS(t
j
-1) (6) |
CMI
R
(t
j
) (7) |
|---|---|---|---|---|---|---|
| 0 | 0 | 0 | 111 | 0.0000 | 1.0000 | 0.0000 |
| 1 | 153 | 1 | 109 | 0.0092 | 1.0000 | 0.0092 |
| 2 | 248 | 1 | 100 | 0.0100 | 0.9261 | 0.0184 |
| 3 | 274 | 1 | 95 | 0.0105 | 0.8888 | 0.0278 |
| 4 | 277 | 1 | 94 | 0.0106 | 0.8794 | 0.0372 |
| 5 | 295 | 1 | 93 | 0.0108 | 0.8701 | 0.0465 |
| 6 | 367 | 1 | 91 | 0.0110 | 0.8513 | 0.0559 |
| 7 | 399 | 1 | 86 | 0.0116 | 0.8326 | 0.0655 |
| 8 | 524 | 1 | 78 | 0.0128 | 0.8130 | 0.0760 |
| 9 | 1660 | 1 | 15 | 0.0667 | 0.7131 | 0.1235 |